Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
3.070
-0.130 (-4.06%)
Nov 26, 2025, 9:38 AM EST - Market open
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $13.63 million as of November 26, 2025. Its market cap has decreased by -52.93% in one year.
Market Cap
13.63M
Enterprise Value
15.10M
1-Year Change
-52.93%
Ranking
Category
Stock Price
$3.07
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $13.63M, a decrease of -84.62%. That is a compound annual growth rate of -34.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 14.21M | -60.99% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |